Journal of Peking University(Health Sciences) >
Sjögren's syndrome combined with cold agglutinin disease: A case report
Received date: 2023-08-02
Online published: 2023-12-11
Sjögren's syndrome(SS)is a chronic autoimmune disease that affects exocrine glands, especially salivary and lacrimal glands. The main clinical manifestations are dry mouth and dry eyes, but also multi-organ and multi-system can be involved. Cold agglutinin disease(CAD)is an autoimmune disease characterized by red blood cell agglutination in the blood vessels of extremities caused by cold agglutinin at low temperature, resulting in skin microcirculation disturbance, or hemolytic anemia. Cold agglutinin disease is divided into two categories, primary cold agglutinin disease and secondary cold agglutinin disease. Primary cold agglutinin disease is characterized with cold agglutinin titer of 1 ∶4 000 or more and positive Coomb's test. However, the Coomb's test is not necessarily positive and the cold agglutinin titer is between 1 ∶32 and 1 ∶4 000 in secondary cold agglutinin disease. Here, we reported an elderly patient admitted to hospital due to fever. He was diagnosed with respiratory infection, but he showed incompletely response to the anti-infection treatment. Further laboratory tests showed the patient with positive ANA and anti-SSA antibodies. Additionally, the patient complained that he had dry mouth and dry eyes for 1 year. Schirmer test and salivate gland imaging finally confirmed the diagnosis Sjogren's syndrome. During the hospital stay, the blood clots were found in the anticoagulant tubes. Hemolytic anemia was considered as the patient had anemia with elevated reticulocytes and indirect bilirubin. In addition, further examination showed positive cold agglutination test with a titer of 1 ∶1 024, and cold agglutinin disease was an important type of cold-resistant autoimmune hemolytic anemia. Furthermore, the patient developed cyanosis after ice incubating at the tip of the nose. Hence, the patient was diagnosed as CAD and he was successfully treated with glucocorticoids instead of anti-infection treatments. Hence, the patient was diagnosed with SS combined with secondary CAD. SS combined CAD are rarely reported, and they are both autoimmune diseases. The abnormal function of B lymphocytes and the production of autoantibodies might be the common pathogenesis of them. Cold agglutinin disease can lead to severe hemolytic anemia, even life-threatening. In clinical practice, timely recognizing and dealing with CAD might promote the prognosis of the patient.
Key words: Sjögren's syndrome; Cold agglutinin; Infection; Glucocorticoid
Li-fang WANG , Lian-jie SHI , Wu NING , Nai-shu GAO , Kuan-ting WANG . Sjögren's syndrome combined with cold agglutinin disease: A case report[J]. Journal of Peking University(Health Sciences), 2023 , 55(6) : 1130 -1134 . DOI: 10.19723/j.issn.1671-167X.2023.06.027
| 1 | Berentsen S . How I manage patients with cold agglutinin disease[J]. Br J Haematol, 2018, 181 (3): 320- 330. |
| 2 | Berentsen S , Ulvestad E , Langholm R , et al. Primary chronic cold agglutinin disease: A population based clinical study of 86 patients[J]. Haematologica, 2006, 91 (4): 460- 466. |
| 3 | Broome C M . Diagnosis and treatment of cold agglutinin disease[J]. Clin Adv Hematol Oncol, 2019, 17 (3): 162- 165. |
| 4 | 刘京倩, 张凤奎. 冷凝集素疾病的诊疗进展[J]. 中华血液学杂志, 2022, 43 (6): 524- 528. |
| 5 | Berentsen S . New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia[J]. Front Immunol, 2020, 11, 590. |
| 6 | Kikuchi M , Inagaki T . A case of primary Sj?gren's syndrome associated with low titer cold agglutinin disease[J]. Clin Exp Rheumatol, 2002, 20 (4): 577- 578. |
| 7 | Bouaziz J D , Yanaba K , Tedder T F . Regulatory B cells as inhibitors of immune responses and inflammation[J]. Immunol Rev, 2008, 224 (1): 201- 214. |
| 8 | 蔡丽敏, 陈志强. B细胞活化因子与干燥综合征[J]. 国际皮肤性病学杂志, 2007, 33 (2): 95- 97. |
| 9 | 王琳, 张文, 李梦涛, 等. 原发性干燥综合征患者及其一级亲属外周血记忆性B细胞、B细胞激活因子及与临床指标的相关性[J]. 协和医学杂志, 2010, 1 (2): 132- 136. |
| 10 | Berentsen S , Malecka A , Randen U , et al. Cold agglutinin disease: Where do we stand, and where are we going?[J]. Clin Adv Hematol Oncol, 2020, 18 (1): 35- 44. |
| 11 | Hill QA , Stamps R , Massey E , et al. The diagnosis and management of primary autoimmune haemolytic anaemia[J]. Br J Haematol, 2017, 176 (3): 395- 411. |
| 12 | Rossi G , Gramegna D , Paoloni F , et al. Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: A phase 2 prospective GIMEMA study[J]. Blood, 2018, 132 (5): 547- 550. |
| 13 | Zaninoni A , Giannotta J A , Gallì A , et al. The immunomodula-tory effect and clinical efficacy of daratumumab in a patient with cold agglutinin disease[J]. Front Immunol, 2021, 12, 649441. |
| 14 | J?ger U , D'Sa S , Sch?rgenhofer C , et al. Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: A first-in-human trial[J]. Blood, 2019, 133 (9): 893- 901. |
| 15 | R?th A , Bommer M , Hüttmann A , et al. Eculizumab in cold agglutinin disease (DECADE): An open-label, prospective, bicentric, nonrandomized phase 2 trial[J]. Blood Adv, 2018, 2 (19): 2543- 2549. |
| 16 | Kotani T , Takeuchi T , Kawasaki Y , et al. Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus[J]. Lupus, 2006, 15 (10): 683- 685. |
| 17 | Malesci D , La Montagna G . Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab[J]. Rheumatology (Oxford), 2008, 47 (5): 734- 735. |
/
| 〈 |
|
〉 |